ACO Name and Location
PQN — Georgia LLC
950 N. Glebe Rd
Suite 700
Arlington, VA 22003
ACO Primary Contact
Zia Khan, MD
Phone: 571-366-8850
Email: Zia.Khan@priviahealth.com
Organizational Information
ACO Participants:
ACO Participants | ACO Participant in Joint Venture |
---|---|
Bainbridge Medical Associates PC | Y |
BCG Medical Group LLC | Y |
Bohler Family Practice PC | Y |
C. Thomas Bevill III MD, PC | Y |
Family Medicine Specialist, PC | Y |
Family Practice Associates LLC | Y |
Frederick R. Yarid, M.D. | Y |
Garrett Family Medicine LLC | Y |
High Mountain Healthcare, LLC | Y |
Hillandale Internal Medicine P.C | Y |
Howard Ellison MD PC | Y |
John A Keller MD PC | Y |
Jorge Amador MD LLC | Y |
Lawrence A. Adjei, APMC | Y |
Mcintosh Clinic, PC | Y |
Middle Georgia Family | Y |
Perisseia Physicians, LLC | Y |
Perry Family Practice LLC | Y |
Prime Care Medical Services PC | Y |
Privia Medical Group Of Georgia, LLC | Y |
Privia Medical Group Tennessee LLC | Y |
Randy B Cronic, M.D. PC | Y |
Southcoast Medical Group LLC | Y |
Suzanne L. Nunn, MD PC | Y |
Tate Medical Associates, LLC | Y |
The Corporation of Mercer University | Y |
The Veranda, PC | Y |
Vibrant Family Medicine, P.C. | Y |
Unicoi Medical Associates | Y |
ACO Governing Body:
Member First Name | Member Last Name | Member Title/Position | Member’s Voting Power (Expressed as a percentage) | Membership Type | ACO Participant TIN Legal Business Name/DBA, if Applicable |
---|---|---|---|---|---|
Zia | Khan | Executive | 5.56% | ACO Executive | Privia Health |
Aaron | Williams | Executive | 5.56% | ACO Executive | Privia Health |
Ryan | Graham | Executive | 5.55% | ACO Executive | Privia Health |
Michael | Gee | Physician | 8.34% | ACO Participant Representative | Privia Medical Group – Georgia |
Charlotte | Grayson-Mathis | Physician | 8.33% | ACO Participant Representative | Privia Medical Group – Georgia |
Frank | Cole | Physician | 8.33% | ACO Participant Representative | Privia Medical Group – Georgia |
Joseph | Stubbs | Physician | 8.34% | ACO Participant Representative | Privia Medical Group – Georgia |
Robert | Weeks | Physician | 8.33% | ACO Participant Representative | Privia Medical Group – Georgia |
Garrett | White | Physician | 8.33% | ACO Participant Representative | Privia Medical Group – Georgia |
W Scott | Bohlke | Physician | 8.33% | ACO Participant Representative | Privia Medical Group – Georgia |
William | Cooper | Physician | 8.33% | ACO Participant Representative | Privia Medical Group – Georgia |
Monica | Manocha | Physician | 8.34% | ACO Participant Representative | Privia Medical Group – Georgia |
James | Thomas, Jr | Patient | 8.33% | Medicare Beneficiary | N/A |
Key ACO Clinical and Administrative Leadership:
- ACO Executive: Zia Khan, MD
- Medical Director: Zia Khan, MD
- Compliance Officer: Stephanie Clark
- Quality Assurance/Improvement Officer: Gwen Wyles
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name & Position |
---|---|
PQN – Georgia, LLC Board | Michael Gee, MD, Chair |
Membership Committee | Frank Cole, MD, Chair |
Steering Committee | Zia Khan, MD, Chair |
Clinical Performance Committee | Zia Khan, MD, Chair |
Finance Committee | Aaron Williams, Chair |
Compliance Committee | Zia Khan, MD, Chair |
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2023: $19,296,024
- Performance Year 2022: $17,369,116
- Second Agreement Period
- Performance Year 2021: $13,117,176
- Performance Year 2020: $8,748,128
- First Agreement Period
- Performance Year 2019: $5,618,143
- Performance Year 2018: $6,112,852
- Performance Year 2017: $4,954,482
Shared Savings Distribution
-
- Third Agreement Period
- Performance Year 2023
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2022
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2023
- Third Agreement Period
-
- Second Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2020
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2021
- Second Agreement Period
-
- First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2018
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2017
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2019
- First Agreement Period
Quality Performance Results
2023 Quality Performance Results:
Quality Performance Results are based on CMS Web Interface Measure Set
MEASURE # | MEASURE NAME | COLLECTION TYPE | REPORTED PERFORMANCE RATE | CURRENT YEAR MEAN PERFORMANCE RATE (SSP ACO’S) |
---|---|---|---|---|
Measure # 001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | CMS Web Interface | 6.05 | 9.84 |
Measure # 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 92.43 | 80.97 |
Measure # 236 | Controlling High Blood Pressure | CMS Web Interface | 86.71 | 77.80 |
Measure # 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 96.39 | 89.42 |
Measure # 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 83.43 | 70.76 |
Measure # 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 83.33 | 79.29 |
Measure # 113 | Colorectal Cancer Screening | CMS Web Interface | 85.90 | 77.14 |
Measure # 112 | Breast Cancer Screening | CMS Web Interface | 85.61 | 80.36 |
Measure # 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 84.45 | 87.05 |
Measure # 370 | Depression Remission at Twelve Months | CMS Web Interface | 37.04 | 16.58 |
Measure # 321 | CAHPS for MIPS | CMS Web Interface | 8.26 | 6.25 |
Measure # 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | Administrative Claims | 0.1552 | 0.1553 |
Measure # 484 | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions | Administrative Claims | N/A | 35.39 |
CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 85.63 | 83.68 |
CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS Survey | 94.44 | 93.69 |
CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 93.04 | 92.14 |
CAHPS-4 | Access to Specialists | CAHPS for MIPS Survey | 79.39 | 75.97 |
CAHPS-5 | Health Promotion and Education | CAHPS for MIPS Survey | 67.90 | 63.93 |
CAHPS-6 | Shared Decision Making | CAHPS for MIPS Survey | 63.02 | 61.60 |
CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS Survey | 76.53 | 74.12 |
CAHPS-8 | Care Coordination | CAHPS for MIPS Survey | 88.19 | 85.77 |
CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 93.18 | 92.31 |
CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 28.07 | 26.69 |
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov